Patents by Inventor Olga Vladimirovna Zubkova

Olga Vladimirovna Zubkova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses
    Patent number: 11186603
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical and cosmeceutical compositions containing the compounds, and methods of treating cancer, inflammation, diabetic nephropathy, neurodegenerative disorders, Niemann-Pick Type C disease, or dermatological conditions.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: November 30, 2021
    Assignees: VICTORIA LINK LIMITED
    Inventors: Jeremy E. Turnbull, Andrew Munkacsi, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • HEPARAN SULFATE GLYCOMIMETIC COMPOUNDS AND THEIR PHARMACEUTICAL AND COSMECEUTICAL USES
    Publication number: 20200131217
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical and cosmeceutical compositions containing the compounds, and methods of treating cancer, inflammation, diabetic nephropathy, neurodegenerative disorders, Niemann-Pick Type C disease, or dermatological conditions.
    Type: Application
    Filed: March 23, 2017
    Publication date: April 30, 2020
    Inventors: Jeremy E. TURNBULL, Andrew MUNKACSI, Peter Charles TYLER, Olga Vladimirovna ZUBKOVA
  • Saccharide dendritic cluster compounds as inhibitors of BACE-1
    Patent number: 9879041
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Grant
    Filed: November 28, 2013
    Date of Patent: January 30, 2018
    Assignees: Victoria Link Limited, University of Liverpool
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova, Jeremy E. Turnbull
  • Dendritic core compounds
    Patent number: 9828341
    Abstract: The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes for preparing the compounds.
    Type: Grant
    Filed: November 28, 2013
    Date of Patent: November 28, 2017
    Assignee: Victoria Link Limited
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Saccharide Dendritic Cluster Compounds as Inhibitors of Bace-1
    Publication number: 20170152279
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: November 28, 2013
    Publication date: June 1, 2017
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova, Jeremy E. Turnbull
  • Oligosaccharide Compounds
    Publication number: 20160185881
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: March 7, 2016
    Publication date: June 30, 2016
    Inventors: Ralf Schwörer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Oligosaccharide compounds
    Patent number: 9315587
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: April 19, 2016
    Assignees: Victoria Link Limited, The University of Liverpool
    Inventors: Ralf Schwoerer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Saccharide Dendritic Cluster Compounds as Inhibitors of Bace-1
    Publication number: 20150291644
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: November 28, 2013
    Publication date: October 15, 2015
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova, Jeremy E. Turnbull
  • DENDRITIC CORE COMPOUNDS
    Publication number: 20150291522
    Abstract: The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes for preparing the compounds.
    Type: Application
    Filed: November 28, 2013
    Publication date: October 15, 2015
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Oligosaccharide Compounds
    Publication number: 20140051659
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: March 9, 2012
    Publication date: February 20, 2014
    Applicants: The University of Liverpool, Callaghan Innovation Research Limited
    Inventors: Ralf Schwoerer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
    Patent number: 8173662
    Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5?-methylthioadenosine phosphorylases (MTAP), 5?-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: May 8, 2012
    Assignees: Industrial Research Limited, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Gary Brian Evans, Richard Hubert Furneaux, Dirk Henning Lenz, Vern L. Schramm, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Inhibitors of nucleoside phoshorylases and nucleosidases
    Publication number: 20090239885
    Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5?-methylthioadenosine phosphorylases (MTAP), 5?-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: June 3, 2009
    Publication date: September 24, 2009
    Inventors: Gary Brian Evans, Richard Hubert Furneax, Dirk Henning Lenz, Vern L. Schramm, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Inhibitors of nucleoside phosphorylases and nucleosidases
    Publication number: 20090233948
    Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5?-methylthioadenosine phosphorylases (MTAP), 5?-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: May 22, 2006
    Publication date: September 17, 2009
    Inventors: Gary Brian Evans, Richard Hubert Furneaux, Vern L. Schramm, Peter Charles Tyler, Simon Peter Harold Mee, Olga Vladimirovna Zubkova
  • 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
    Patent number: 7553839
    Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5?-methylthioadenosine phosphorylases (MTAP), 5?-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: June 30, 2009
    Assignees: Industrial Research Limited, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Gary Brian Evans, Richard Hubert Furneaux, Dirk Henning Lenz, Vern L. Schramm, Peter Charles Tyler, Olga Vladimirovna Zubkova